Close
ACHEMA MIDDLE EAST 2026

Fycompa for Adjunctive treatment of Partial Onset Seizures launched in China

Eisai Co., Ltd announced hat it has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa®, generic name perampanel) for use in adjunctive...

Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China

Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand...

Catalent Completes Purchase of Biologics Fill-Finish and Oral Solid Dose Facility in Anagni, Italy

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced the...

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

Merck known as MSD outside the United States and Canada, announced an exclusive worldwide research collaboration and license agreement with Taiho Pharmaceutical Co, Ltd.,...

Royal DSM Completes Acquisition of Specialty Dairy Solutions Provider CSK

The collaboration between Royal DSM and CSK will enable DSM to cater to the growing dairy markets around the globe. The deal was closed...

FedEx Express ships pharma goods for Japanese clinical trial

FedEx Express is supporting a clinical trial run by Life Science Center in Tokyo, Japan, by shipping pharma products to and from the Center...

Dicerna, Novo Nordisk sign RNAi deal for liver-related cardio-metabolic diseases

US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs for liver-related cardio-metabolic diseases. In...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...